Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - exemestane - film-coated tablet - 25 milligram(s) - aromatase inhibitors; exemestane

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - exemestane (unii: ny22hmq4bx) (exemestane - unii:ny22hmq4bx) - exemestane 25 mg - aromasin is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to aromasin for completion of a total of five consecutive years of adjuvant hormonal therapy. aromasin is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. aromasin tablets are contraindicated in patients with a known hypersensitivity to the drug or to any of the excipients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

beacon pharmaceuticals ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - exemestane - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - exemestane - oral tablet - 25mg